Members-only Site   |   Print Page   |   Contact Us   |   Sign In   |   Register
Essential Elements of Hazardous Drug Compounding
Tell a Friend About This EventTell a Friend
Essential Elements of Hazardous Drug Compounding

8/17/2019 to 8/18/2019
When: Aug 17 - Aug 18, 2019
Where: Las Vegas, Nevada 
United States
Contact: (844) 408-9453

« Go to Upcoming Event List  



Are you currently compounding with any of these active pharmaceutical ingredients: apomorphone, azathioprin, cyclophosphamide, cyclosporine, diethylstilbestrol, estradiol, fluorouracil, medroxyprogesterone, phenytoin, progesterone, spironolactone, or tacrolimus?


If so, you must be compliant with General Chapter <800> Hazardous Drugs – Handling in Healthcare Settings, which was formally published February 1, 2016 in the First Supplement to USP 39-NF 34. In an effort to provide an adequate timeframe to implement USP <800>, the chapter has a delayed official implementation date of July 1, 20181. While a two-year window may seem to provide sufficient time for preparation, it is important to note that this implementation date is when entities must be compliant; waiting too long to begin the process could negatively impact your practice. It is critical that pharmacies that compound hazardous drugs prepare their equipment, processes, and staff for the requirements of USP <800>. During this training activity, you will learn about personal protective equipment, engineering controls, closed system transfer devices, facility design, workflow considerations, and safe handling practices. Moreover, you will learn how to minimize and prevent hazardous drug contamination and exposure through: powder containment techniques, waste disposal, staff training, and the handling of emergency situations such as chemical spills.


Click here for more information.

Association Management Software Powered by YourMembership  ::  Legal